LXG.H — Lexagene Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Lexagene Holdings, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

	2018 February 28th	2019 February 28th	2020 February 29th	2021 February 28th	R2022 February 28th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.65	0.671	3.19	9.62	4.72
Net Total Accounts Receivable
Net Total Receivables	0.013	0	0.003	0.044	0.014
Total Inventory
Prepaid Expenses
Total Current Assets	2.96	0.942	3.47	11.1	6.57
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.683	0.682	2.45	2.01	1.53
Net Intangible Assets
Other Long Term Assets
Total Assets	3.72	1.7	5.99	13.2	8.2
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.257	0.319	0.528	1.02	0.897
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.257	0.319	2.13	2.31	1.73
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	3.47	1.38	3.86	10.9	6.47
Total Liabilities & Shareholders' Equity	3.72	1.7	5.99	13.2	8.2
Total Common Shares Outstanding